First Bank & Trust grew its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 23.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 490 shares of the healthcare conglomerate’s stock after acquiring an additional 93 shares during the quarter. First Bank & Trust’s holdings in UnitedHealth Group were worth $122,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Ipswich Investment Management Co. Inc. acquired a new position in UnitedHealth Group during the fourth quarter worth about $40,000. OLD Second National Bank of Aurora raised its stake in UnitedHealth Group by 70.0% during the fourth quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock worth $42,000 after acquiring an additional 70 shares in the last quarter. Contravisory Investment Management Inc. raised its stake in UnitedHealth Group by 172.1% during the fourth quarter. Contravisory Investment Management Inc. now owns 185 shares of the healthcare conglomerate’s stock worth $46,000 after acquiring an additional 117 shares in the last quarter. CX Institutional raised its stake in UnitedHealth Group by 475.0% during the fourth quarter. CX Institutional now owns 322 shares of the healthcare conglomerate’s stock worth $80,000 after acquiring an additional 266 shares in the last quarter. Finally, NewSquare Capital LLC increased its stake in shares of UnitedHealth Group by 15.6% in the fourth quarter. NewSquare Capital LLC now owns 333 shares of the healthcare conglomerate’s stock valued at $83,000 after buying an additional 45 shares during the period. 85.31% of the stock is owned by hedge funds and other institutional investors.
In related news, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, January 17th. The stock was sold at an average price of $260.55, for a total value of $3,908,250.00. Following the sale, the director now directly owns 193,872 shares in the company, valued at $50,513,349.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 6,090 shares of the company’s stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total value of $1,715,674.80. Following the completion of the sale, the director now owns 1,711,584 shares in the company, valued at $482,187,444.48. The disclosure for this sale can be found here. Insiders sold 26,090 shares of company stock worth $6,956,975 over the last quarter. 0.87% of the stock is currently owned by company insiders.
Several research analysts have recently issued reports on the company. Credit Suisse Group reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Friday. Oppenheimer upped their price objective on UnitedHealth Group from $300.00 to $305.00 and gave the company an “outperform” rating in a research note on Wednesday, January 16th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, January 15th. Stephens assumed coverage on UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 price objective for the company. Finally, Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Friday, January 11th. One investment analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $297.80.
Shares of UNH stock opened at $261.90 on Friday. UnitedHealth Group Inc has a one year low of $212.01 and a one year high of $287.94. The company has a market capitalization of $251.96 billion, a P/E ratio of 20.33, a P/E/G ratio of 1.38 and a beta of 0.86. The company has a current ratio of 0.73, a quick ratio of 0.69 and a debt-to-equity ratio of 0.64.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.20 by $0.08. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The business had revenue of $58.42 billion for the quarter, compared to analysts’ expectations of $58.01 billion. During the same period in the prior year, the business posted $2.59 earnings per share. The firm’s revenue was up 12.2% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Inc will post 14.62 EPS for the current fiscal year.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Should You Consider an Index Fund?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).